Carole Longson
Honorary Professor of Health Technology Assessment, University of Manchester
Carole Longson is listed as Honorary Professor of Health Technology Assessment, University of Manchester. Carole spoke at ISPOR Europe 2026 in November 2026 (moderator, “The Historical Linear Life Science Model is Dead and Requires Rethinking to Adapt to a Rapidly Changing Ecosystem”). Carole is scheduled to speak at ISPOR Europe 2026 on 10 November 2026.
Compiled from published conference agendas; not yet confirmed by Carole. Is this you? Claim this profile.
About
Carole Longson has over 30 years of executive and board experience in life sciences and is an internationally respected leader in Health Technology Assessment and Market Access. After a career in drug discovery at GSK, she spent 18 years at NICE pioneering its Technology Appraisal and Health Tech Evaluation programs, later serving as Chief Scientific Officer at the Association of the British Pharmaceutical Industry. A former HTAi President and EUnetHTA Executive Committee member, she has advised the European Commission and WHO. She is currently Vice Chair of Medicines Discovery Catapult UK and senior counsel in HTA and market access.
Upcoming
ISPOR Europe 2026 8 November 2026 – 11 November 2026
- Plenary Session 2: We Optimize Treatments—But How Do We Optimize the System? Speaker · 10 November 2026